Augtyro 160 mg/1
repotrectinib · CAPSULE · E.R. Squibb & Sons, L.L.C.
No Recall History
Plain English
Augtyro is a capsule containing repotrectinib at 160 mg/1, taken oral. Manufactured by E.R. Squibb & Sons, L.L.C..
Key Facts
- Brand Name
- Augtyro
- Generic Name
- repotrectinib
- NDC Code (Product)
0003-4160- Manufacturer
- E.R. Squibb & Sons, L.L.C.
- Strength
- 160 mg/1
- Dosage Form
- CAPSULE
- Route
- ORAL
- Marketing Status
- Application #
- NDA218213
- Drug Class
- Kinase Inhibitor [EPC]
- Marketing Start
- 11/01/2024
Recall History
No Recall HistoryFrequently Asked Questions
What is Augtyro used for?
Augtyro contains repotrectinib. It is a capsule taken oral. Consult your doctor for specific uses.
Is Augtyro a controlled substance?
Augtyro is not classified as a controlled substance by the DEA.
What is the generic name for Augtyro?
The generic name for Augtyro is repotrectinib. There are no other listed brand versions of repotrectinib.
What is the NDC code for Augtyro 160 mg/1?
The NDC (National Drug Code) for Augtyro 160 mg/1 is 0003-4160, listed by E.R. Squibb & Sons, L.L.C..
Other Augtyro Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)